drugset / Trial / NCT02918630

E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia

NCT02918630

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among individuals diagnosed with schizophrenia compared to nicotine patch alone.

Timeline

Start
2016-10
Primary completion
2017-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown 21 mg Other

Indications